Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB
On the one hand, the innovation field focuses on the development and establishment of human in-vitro test models such as 3D tissue models and cell-based 2D assays. On the other hand, those models are applied for the preclinical testing of drugs, the determination of toxicity and allergenicity of, e.g., cosmetics and chemicals, as well as for clinical applications in personalized medicine.
We have many years of expertise in the development of cell lines, for example to establish assays, the production of biologicals or the handling of (pathogenic) microorganisms.
A focus is on the integration of immune components into microphysiological tissues or reporter cell lines and the use of cell systems as biosensors.